Thermo Fisher selling some assets to GE for $1.06B

WALTHAM, Massachusetts (AP) — Scientific instrument maker Thermo Fisher is selling its cell culture, gene modulation and magnetic beads businesses to a General Electric Co. division for approximately $1.06 billion.

The businesses will become part of GE Healthcare's life sciences unit. Thermo Fisher Scientific Inc. said Monday it is selling the businesses to speed up European Commission approval of its pending $13.6 billion acquisition of Life Technologies Corp. The company said that deal still needs approval from the Federal Trade Commission, but that based on talks with the FTC, it doesn't believe any additional asset sales will be needed to receive U.S. approval.

Thermo Fisher expects the Life Technologies to close early this year.

Related Headlines

  • Bourbon truly American, despite foreign ties

    Kentucky bourbon remains authentically American, whiskey insiders maintain — even when some of its distillers answer to foreign companies. The planned $13.62 billion ... 

  • US high-tech startup hopes to change biking

    A U.S. startup is launching a new device that transforms almost any bicycle into an electric-hybrid vehicle using an app on a smartphone. The device, called the Copenhagen ... 

  • Actavis to buy Forest Labs in $25 billion deal

    Irish drugmaker Actavis PLC plans to buy Forest Laboratories Inc. for about $25 billion, catapulting little-known Actavis into the world's No. 15 drug company, with an unusual ... 

  • Jonathan Copina, Dan Ryan

    Asian stocks up after US gains, China rebound

    Asian stocks rose Monday after U.S. markets gained on stronger corporate profits and China reported a rebound in economic growth in the latest quarter. Oil edged up, staying ...